BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 23194157)

  • 1. Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.
    Winterfeld U; Allignol A; Panchaud A; Rothuizen LE; Merlob P; Cuppers-Maarschalkerweerd B; Vial T; Stephens S; Clementi M; De Santis M; Pistelli A; Berlin M; Eleftheriou G; Maňáková E; Buclin T
    BJOG; 2013 Mar; 120(4):463-71. PubMed ID: 23194157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of cetirizine during pregnancy. A prospective observational cohort study.
    Weber-Schoendorfer C; Schaefer C
    Reprod Toxicol; 2008 Sep; 26(1):19-23. PubMed ID: 18571373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes.
    Taguchi N; Rubin ET; Hosokawa A; Choi J; Ying AY; Moretti ME; Koren G; Ito S
    Reprod Toxicol; 2008 Oct; 26(2):175-7. PubMed ID: 18640262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study.
    Weber-Schoendorfer C; Oppermann M; Wacker E; Bernard N; ; Beghin D; Cuppers-Maarschalkerweerd B; Richardson JL; Rothuizen LE; Pistelli A; Malm H; Eleftheriou G; Kennedy D; Kadioglu Duman M; Meister R; Schaefer C
    Br J Clin Pharmacol; 2015 Oct; 80(4):727-39. PubMed ID: 25808588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study.
    Schaefer C; Hannemann D; Meister R; Eléfant E; Paulus W; Vial T; Reuvers M; Robert-Gnansia E; Arnon J; De Santis M; Clementi M; Rodriguez-Pinilla E; Dolivo A; Merlob P
    Thromb Haemost; 2006 Jun; 95(6):949-57. PubMed ID: 16732373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the average drug exposure in pregnant women affect pregnancy outcome? A comparison of two approaches to estimate the baseline risks of adverse pregnancy outcome.
    Wacker E; Navarro A; Meister R; Padberg S; Weber-Schoendorfer C; Schaefer C
    Pharmacoepidemiol Drug Saf; 2015 Apr; 24(4):353-60. PubMed ID: 25644395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy outcome after exposure to the probiotic Lactobacillus in early pregnancy.
    Lee JE; Han JY; Choi JS; Ahn HK; Lee SW; Kim MH; Ryu HM; Yang JH; Nava-Ocampo AA; Koren G
    J Obstet Gynaecol; 2012 Apr; 32(3):227-9. PubMed ID: 22369393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants.
    Chambers CD; Johnson D; Xu R; Luo Y; Louik C; Mitchell AA; Schatz M; Jones KL;
    Vaccine; 2013 Oct; 31(44):5026-32. PubMed ID: 24016809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.
    Weber-Schoendorfer C; Hannemann D; Meister R; Eléfant E; Cuppers-Maarschalkerweerd B; Arnon J; Vial T; Rodriguez-Pinilla E; Clementi M; Robert-Gnansia E; De Santis M; Malm H; Dolivo A; Schaefer C
    Reprod Toxicol; 2008 Sep; 26(1):24-30. PubMed ID: 18585452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is induced abortion with misoprostol a risk factor for late abortion or preterm delivery in subsequent pregnancies?
    Winer N; Resche-Rigon M; Morin C; Ville Y; Rozenberg P
    Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):53-6. PubMed ID: 19427095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy outcome after in utero exposure to colchicine.
    Diav-Citrin O; Shechtman S; Schwartz V; Avgil-Tsadok M; Finkel-Pekarsky V; Wajnberg R; Arnon J; Berkovitch M; Ornoy A
    Am J Obstet Gynecol; 2010 Aug; 203(2):144.e1-6. PubMed ID: 20579964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An observational outcomes study from 1966-2008, examining pregnancy and neonatal outcomes from dialysed women using data from the ANZDATA Registry.
    Shahir AK; Briggs N; Katsoulis J; Levidiotis V
    Nephrology (Carlton); 2013 Apr; 18(4):276-84. PubMed ID: 23441694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy outcome after exposure to oral contraceptives during the periconceptional period.
    Ahn HK; Choi JS; Han JY; Kim MH; Chung JH; Ryu HM; Kim MY; Yang JH; Koong MK; Nava-Ocampo AA; Koren G
    Hum Exp Toxicol; 2008 Apr; 27(4):307-13. PubMed ID: 18684801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study.
    Diav-Citrin O; Shechtman S; Gotteiner T; Arnon J; Ornoy A
    Teratology; 2001 May; 63(5):186-92. PubMed ID: 11320529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study.
    Gur C; Diav-Citrin O; Shechtman S; Arnon J; Ornoy A
    Reprod Toxicol; 2004; 18(1):93-101. PubMed ID: 15013068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of breast cancer during pregnancy: an observational study.
    Loibl S; Han SN; von Minckwitz G; Bontenbal M; Ring A; Giermek J; Fehm T; Van Calsteren K; Linn SC; Schlehe B; Gziri MM; Westenend PJ; Müller V; Heyns L; Rack B; Van Calster B; Harbeck N; Lenhard M; Halaska MJ; Kaufmann M; Nekljudova V; Amant F
    Lancet Oncol; 2012 Sep; 13(9):887-96. PubMed ID: 22902483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study.
    Diav-Citrin O; Shechtman S; Ornoy S; Arnon J; Schaefer C; Garbis H; Clementi M; Ornoy A
    J Clin Psychiatry; 2005 Mar; 66(3):317-22. PubMed ID: 15766297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy outcome of women exposed to azathioprine during pregnancy.
    Goldstein LH; Dolinsky G; Greenberg R; Schaefer C; Cohen-Kerem R; Diav-Citrin O; Malm H; Reuvers-Lodewijks ME; Rost van Tonningen-van Driel MM; Arnon J; Ornoy A; Clementi M; Di Gianantonio E; Koren G; Braunstein R; Berkovitch M
    Birth Defects Res A Clin Mol Teratol; 2007 Oct; 79(10):696-701. PubMed ID: 17847119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between congenital toxoplasmosis and preterm birth, low birthweight and small for gestational age birth.
    Freeman K; Oakley L; Pollak A; Buffolano W; Petersen E; Semprini AE; Salt A; Gilbert R;
    BJOG; 2005 Jan; 112(1):31-7. PubMed ID: 15663394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuation of pregnancy after first-trimester exposure to mifepristone: an observational prospective study.
    Bernard N; Elefant E; Carlier P; Tebacher M; Barjhoux CE; Bos-Thompson MA; Amar E; Descotes J; Vial T
    BJOG; 2013 Apr; 120(5):568-74. PubMed ID: 23346916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.